Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800015526Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in None comparing Sevoflurane group with Propofol group (2 arms). Primary endpoints: Neonatal bispectral index and Apgar score. Planned start Apr 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800015526.